MedTrace Logo

Prevalence of FID and QoL in Patients with Oncological and with Haematological Malignancies

NCT05333913 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2025-03-28

No results posted yet for this study

Summary

Prospective single-center observational study assessing prevalence of FID (Laboratory work-up) and Quality of Life (Questionnaire) in adult patients with oncological and with haematological malignancies within four weeks prior to disease-directed therapy.

Conditions

  • Functional Iron Deficiency

Sponsors & Collaborators

  • Luzerner Kantonsspital

    lead OTHER

Principal Investigators

  • Axel Ruefer, MD · Hematology Department, Luzerner Kantonsspital, 6000 Luzern 16, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-07
Primary Completion
2023-04-04
Completion
2023-04-04

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05333913 on ClinicalTrials.gov